Title : Mutation of EpCAM leads to intestinal barrier and ion transport dysfunction.

Pub. Date : 2015 May

PMID : 25482158






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Based on mutations in CTE patients, an in vivo mouse model was developed, with tamoxifen-inducible deletion of exon 4 in Epcam resulting in mutant protein with decreased expression. Tamoxifen epithelial cell adhesion molecule Mus musculus
2 Tamoxifen treatment of Epcam (Delta4/Delta4) mice resulted in pathological features of villous atrophy and epithelial tufts, similar to those in human CTE patients, within 4 days post induction. Tamoxifen epithelial cell adhesion molecule Mus musculus
3 Tamoxifen-treated Epcam (Delta4/Delta4) mice demonstrated pathological features. Tamoxifen epithelial cell adhesion molecule Mus musculus